• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

苯巴比妥对红霉素在大鼠体内分布、代谢及胆汁排泄的影响。

Effects of phenobarbitone on the distribution, metabolism and biliary excretion of erythromycin in rats.

作者信息

Manzo L, Gregotti C, Richelmi P, Di Nucci A, Bertè F

出版信息

Chemotherapy. 1980;26(3):164-70. doi: 10.1159/000237900.

DOI:10.1159/000237900
PMID:7363713
Abstract

The administration of phenobarbitone to the rat (8 mg/100 g BW) once daily for 3 days significantly decreased the serum and tissue levels of erythromycin administered intraperitoneally (5 mg/100 g BW). Furthermore, phenobarbitone stimulated the hepatic microsomal N-demethylation of erythromycin and increased the biliary concentration and the biliary excretion rate of the unmetabolized antibiotic. These effects were accompanied by augmented liver mass and bile flow. The possibility is discussed that erythromycin concentrates in the bile through a specialized hepatic drug transport system, activated by phenobarbitone.

摘要

连续3天每天给大鼠腹腔注射苯巴比妥(8毫克/100克体重),显著降低了腹腔注射红霉素(5毫克/100克体重)后的血清和组织水平。此外,苯巴比妥刺激了红霉素的肝微粒体N-去甲基化,增加了未代谢抗生素的胆汁浓度和胆汁排泄率。这些作用伴随着肝脏质量和胆汁流量的增加。文中讨论了一种可能性,即红霉素通过苯巴比妥激活的特殊肝脏药物转运系统在胆汁中浓缩。

相似文献

1
Effects of phenobarbitone on the distribution, metabolism and biliary excretion of erythromycin in rats.苯巴比妥对红霉素在大鼠体内分布、代谢及胆汁排泄的影响。
Chemotherapy. 1980;26(3):164-70. doi: 10.1159/000237900.
2
Hepatic cytochrome P-4503A (CYP3A) activity in the elderly.老年人肝脏细胞色素P-4503A(CYP3A)活性
Mech Ageing Dev. 1992 Jun;64(1-2):189-99. doi: 10.1016/0047-6374(92)90106-n.
3
Rat and human liver cytochrome P-450 isoform metabolism of ecteinascidin 743 does not predict gender-dependent toxicity in humans.大鼠和人类肝脏细胞色素P-450同工酶对埃博霉素743的代谢无法预测其在人类中的性别依赖性毒性。
Clin Cancer Res. 2002 Sep;8(9):2952-62.
4
Erythromycin as a specific substrate for cytochrome P4503A isozymes and identification of a high-affinity erythromycin N-demethylase in adult female rats.红霉素作为细胞色素P4503A同工酶的特异性底物以及成年雌性大鼠中高亲和力红霉素N-脱甲基酶的鉴定。
Drug Metab Dispos. 1996 Jan;24(1):23-7.
5
Pharmacokinetic interaction of cytochrome P450 3A-related compounds with rhodamine 123, a P-glycoprotein substrate, in rats pretreated with dexamethasone.细胞色素P450 3A相关化合物与罗丹明123(一种P-糖蛋白底物)在经地塞米松预处理的大鼠体内的药代动力学相互作用。
Drug Metab Dispos. 2001 Feb;29(2):145-51.
6
Use of the erythromycin breath test for in vivo assessments of cytochrome P4503A activity and dosage individualization.
Clin Pharmacol Ther. 2001 Oct;70(4):305-10.
7
Influence of sex and inducer treatment on the high- and low-affinity forms of hepatic microsomal erythromycin N-demethylase in rats.性别和诱导剂处理对大鼠肝微粒体红霉素N-脱甲基酶高亲和力和低亲和力形式的影响。
Can J Physiol Pharmacol. 1990 Dec;68(12):1510-3. doi: 10.1139/y90-229.
8
Induction and inhibition of mouse cytochrome P-450 2B enzymes by musk xylene.麝香二甲苯对小鼠细胞色素P-450 2B酶的诱导和抑制作用
Toxicol Appl Pharmacol. 1997 Jan;142(1):169-77. doi: 10.1006/taap.1996.7927.
9
Prediction of midazolam-CYP3A inhibitors interaction in the human liver from in vivo/in vitro absorption, distribution, and metabolism data.基于体内/体外吸收、分布和代谢数据预测人肝脏中咪达唑仑与细胞色素P450 3A抑制剂的相互作用。
Drug Metab Dispos. 2001 Apr;29(4 Pt 1):443-52.
10
Early postoperative erythromycin breath test correlates with hepatic cytochrome P4503A activity in liver transplant recipients.肝移植受者术后早期红霉素呼气试验与肝细胞色素P4503A活性相关。
Clin Pharmacol Ther. 2001 Nov;70(5):446-54.

引用本文的文献

1
Pharmacokinetic interactions of the macrolide antibiotics.大环内酯类抗生素的药代动力学相互作用。
Clin Pharmacokinet. 1985 Jan-Feb;10(1):63-79. doi: 10.2165/00003088-198510010-00003.
2
Clinical pharmacokinetic properties of the macrolide antibiotics. Effects of age and various pathophysiological states (Part II).大环内酯类抗生素的临床药代动力学特性。年龄及各种病理生理状态的影响(第二部分)
Clin Pharmacokinet. 1989 May;16(5):261-82. doi: 10.2165/00003088-198916050-00001.